Benzamide derivatives and pharmaceutical compositions containing same
USRE39754E1 · kind E1 · reissue
1Cited by
0References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 14, 2003 |
| Grant date | Jul 31, 2007 |
| Priority date | — |
| Expiry date | Aug 14, 2023 |
Classification
- Technology area (CPC —)General
Abstract
The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune diseases, dermatologic diseases and parasitism. In particular, they are highly effective as an anticancer drug, specifically to a hematologic malignancy and a solid carcinoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.